Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis
MAVERIC-2 trial will evaluate the impact of CardiolRx(TM) following cessation of…
Graphite One Receives Indication for Up to $325 Million Financing from the U.S. Export-Import Bank for U.S.-Based Advanced Graphite Material Supply Chain Project
EXIM Letter of Interest is non-binding and indicates potential financing could provide…
Graphite One Enters Into Agreements Providing Exclusive Access to Industry Leading Anode Manufacturing Technology
Execution of the Graphite One-Chenyu Agreements marks key step in providing the…
Interview with Stallion Uranium CEO Drew Zimmerman
Exploring 3000+ Sq/Kms in Canada’s Western Athabasca Basin Against the backdrop of…
Opportunity for Aduro’s Advanced Plastic Recycling Technology
Aduro Clean Technologies, Inc. (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D5) has developed…
Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024
Full clinical data will be reported in an oral presentation at the…